food industry glp 1 How GLP-1 Medications Are Driving and Beverage Innovation – Food Tank How GLP-1 is Shaking Up

Adler AI, Ting S, Dent R, Latimer N (2019) NICE guidance on dapagliflozin with insulin for type 1 diabetes

As we stand on the cusp of breakthroughs in obesity treatment, GLP-1 agonists appear poised to play a significant role in shaping the future landscape of weight management strategies

The consultation should feel thorough

A serve of nuts is 30g, or a handful

GLP-1s are contraindicated in individuals with a history of medullary thyroid carcinoma, a family history of such, or in patients with multiple endocrine neoplasia syndrome type 2

none were underweight (a factor in taking GLP-1 agonist drugs, which cause weight loss)